Squarepoint’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-75,000
Closed -$438K 5229
2025
Q1
$438K Buy
+75,000
New +$395K ﹤0.01% 3428
2024
Q1
Sell
-21,900
Closed -$471K 4725
2023
Q4
$471K Buy
+21,900
New +$391K ﹤0.01% 3047

Other funds holding NVRO

Squarepoint's NVRO Position: Q2 2025 in Review

Squarepoint sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 82,091 shares — an estimated $479K sold.

Squarepoint first reported a position in NVRO in Q4 2016 and held it in 20 quarters. The position peaked at $5.55M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Squarepoint reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 82,091 NEVRO CORP. shares in Q2 2025, an estimated $479K.
  • Squarepoint first reported a position in NEVRO CORP. in Q4 2016 and held it in 20 quarters.
  • Squarepoint's NEVRO CORP. position peaked at $5.55M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.